谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Rationale and Design of a Phase II Trial of Dacomitinib in Advanced Non-Small Cell Lung Cancer Patients with Uncommon Epidermal Growth Factor Receptor Mutations: a Prospective and Single Arm Study (DANCE Study)

Zhang Bo,Shi Chunlei,Gao Zhiqiang,Zhong Hua,Xiong Liwen,Gu Aiqin,Wang Weimin,Chu Tianqing,Zhang Wei,Wang Huimin,Zhang Xueyan,Zhong Runbo,Han Baohui

BMC Cancer（2022）

引用 2|浏览16
关键词
Non-small cell lung cancer,EGFR,Uncommon,Dacomitinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要